How to Get Adderall XR in Indiana

What Indiana Law Says About Prescribing Adderall XR

Indiana follows federal Schedule II rules, which means no refills, no phone-in prescriptions, and a 30-day supply limit per dispensing. Prescribers must hold an active Indiana DEA registration and a valid state controlled-substance license issued by the Indiana Professional Licensing Agency. Telehealth prescribing of Schedule II stimulants became broadly available after the DEA's 2023 telemedicine rule extended COVID-era flexibilities, though the final permanent rule is still pending as of mid-2025. Until a permanent rule is published, audio-video evaluations by DEA-registered clinicians can generate a valid Adderall XR prescription for Indiana patients without a prior in-person visit.

Indiana law (IC 25-1-9) requires that the prescriber establish a valid patient-prescriber relationship before signing any controlled-substance order. A comprehensive evaluation, documented in the medical record, satisfies that requirement whether it occurs in an office or on a video call. The FDA-approved label for Adderall XR specifies that diagnosis must be based on a "complete history and evaluation" and not solely on a symptom checklist. [1]

Prescribers must also check the Indiana Prescription Monitoring Program (INSPECT) database before issuing any Schedule II prescription. INSPECT pulls real-time dispensing data from all Indiana pharmacies, helping clinicians verify a patient is not receiving duplicate controlled-substance prescriptions. Failure to check INSPECT is a licensing violation under 856 IAC 1-1.

Who Can Prescribe Adderall XR in Indiana

Three licensed provider types can legally sign an Adderall XR prescription in Indiana. Each pathway has different wait times and cost structures worth understanding before you make an appointment.

Physicians (MD and DO). Psychiatrists and primary-care physicians account for the majority of stimulant prescriptions nationally. The 2022 IQVIA data showed that roughly 62% of U.S. adult ADHD stimulant prescriptions were written by primary-care providers rather than specialists. In Indiana, a family medicine or internal medicine physician can diagnose ADHD and prescribe Adderall XR as part of routine care, without a referral.

Nurse Practitioners. Indiana grants full practice authority to NPs under IC 25-23-1-19.5, meaning they can evaluate, diagnose, and prescribe Schedule II medications independently. No physician co-signature is required. Many telehealth platforms staffed by NPs serve Indiana patients legally.

Physician Assistants. PAs in Indiana operate under a supervision agreement with a collaborating physician. The PA may prescribe controlled substances if the supervision agreement explicitly authorizes it. Patients using PA-staffed telehealth services should confirm the platform's supervising-physician arrangement is current before completing an evaluation.

The MTA Cooperative Group trial published in Archives of General Psychiatry (N=579 children, 14 months) remains one of the most cited controlled studies of stimulant treatment for ADHD, demonstrating that medication management with methylphenidate produced significantly greater symptom reduction than behavioral treatment alone (P<0.001) in the combined-treatment and medication-only arms. [2] While that study examined methylphenidate, its methodology directly shaped the diagnostic standards now applied to amphetamine-salt prescribing by establishing a benchmark for what "complete evaluation" should include.

Step-by-Step: How to Get a Prescription in Indiana

Getting a first Adderall XR prescription typically takes between 3 and 10 business days, depending on the pathway you choose.

Step 1. Choose your evaluation setting. In-person psychiatric evaluations are booked 4 to 12 weeks out in most Indiana metro areas (Indianapolis, Fort Wayne, Evansville). Telehealth platforms with Indiana-licensed prescribers often schedule initial evaluations within 2 to 5 business days.

Step 2. Complete screening tools before your appointment. Most clinicians ask patients to complete the Adult ADHD Self-Report Scale (ASRS-v1.1) or the Conners' Adult ADHD Rating Scale before the visit. Gather any prior school records, prior psychiatric evaluations, or documentation of symptoms dating to childhood. DSM-5 criteria require that symptoms were present before age 12. [3]

Step 3. Attend the clinical evaluation. The prescriber will review your symptom history, rule out differential diagnoses (anxiety, bipolar disorder, sleep apnea), check your INSPECT record, and discuss medication options. The evaluation typically runs 45 to 90 minutes for an initial visit.

Step 4. Receive the electronic prescription. Schedule II prescriptions in Indiana may be sent electronically to a licensed pharmacy under Indiana's Electronic Prescribing of Controlled Substances (EPCS) rules. The pharmacist verifies your identity with government-issued photo ID on first fill.

Step 5. Fill at a licensed Indiana pharmacy. Chain pharmacies (CVS, Walgreens, Kroger, Meijer), independent pharmacies, and 503A compounding pharmacies can all dispense Adderall XR. Check stock before presenting the prescription; nationwide amphetamine-salt shortages have intermittently affected Indiana supply since 2022. [4]

Telehealth Options for Adderall XR in Indiana

Telehealth prescribing of stimulants in Indiana is permitted under the current DEA emergency extension, and several national platforms maintain Indiana-licensed prescribers. The evaluation process mirrors an in-person visit: video or audio-video call, symptom questionnaires, INSPECT check, and a written diagnosis before any prescription is sent.

The American Psychiatric Association's 2023 telepsychiatry practice guidelines state: "Telehealth evaluations for ADHD are appropriate when a clinician can obtain a thorough history, review prior records, and document that the patient meets DSM-5 criteria." [5] That standard is achievable in a structured 60-minute video visit.

Patients should verify three things before booking with any telehealth service. First, confirm the prescriber holds an active Indiana medical license. Second, confirm the platform's DEA registration covers Schedule II substances. Third, confirm the platform will send prescriptions directly to an Indiana pharmacy (some out-of-state platforms mail paper prescriptions, which can add 2 to 4 days). [6]

Insurance coverage for telehealth ADHD evaluations varies significantly. Indiana Medicaid does not list Adderall XR on its preferred drug list for ADHD. Commercial plans (Anthem BCBS Indiana, UnitedHealthcare Indiana, Ambetter Indiana) generally cover telehealth behavioral-health visits at parity with in-person visits under Indiana's telehealth parity law (IC 27-8-34). [7]

Labs and Baseline Assessments Before Starting Adderall XR

No blood test is required by law before prescribing Adderall XR, but standard clinical practice recommends several baseline checks to reduce risk. The FDA label for Adderall XR states that the drug is contraindicated in patients with "known hypersensitivity to amphetamine products" and warns of cardiovascular risks including increased heart rate and blood pressure. [1]

Clinicians typically obtain or document the following before initiating treatment.

Cardiovascular baseline. Blood pressure and resting heart rate at the evaluation visit. Adderall XR raises mean systolic blood pressure by approximately 2 to 4 mmHg and heart rate by 3 to 6 bpm in adults at therapeutic doses. [8] Patients with uncontrolled hypertension (above 180/110 mmHg) or a history of structural cardiac abnormalities should be cleared by cardiology first.

Weight and height (BMI). Adderall XR suppresses appetite. A meta-analysis of 28 randomized controlled trials found a mean weight reduction of 1.8 kg over 13 weeks in adults on mixed amphetamine salts compared to placebo (P<0.01). [9] Documenting baseline weight allows the prescriber to monitor for clinically significant loss.

Sleep history. Stimulants taken too late in the day worsen insomnia. A baseline Epworth Sleepiness Scale or Pittsburgh Sleep Quality Index score helps differentiate ADHD-related inattention from sleep-disorder-related fatigue, which mimics ADHD symptoms on screening tools. [10]

Substance use history. The prescriber will ask about current or past stimulant misuse, alcohol use disorder, or illicit drug use. This is documented and cross-referenced with INSPECT, not as a barrier to treatment, but as a risk stratification step. [11]

An ECG is not universally required but is recommended by the American Heart Association for patients with a personal or family history of sudden cardiac death, arrhythmia, or congenital heart disease before starting any stimulant. [12]

Adderall XR Dosing and Titration in Indiana Practice

Adderall XR is approved by the FDA for ADHD in patients 6 years and older, and for narcolepsy in patients 6 years and older. The extended-release capsule delivers approximately 50% of the dose immediately and 50% over the following 4 to 8 hours, producing a duration of action of 8 to 12 hours. [1]

Standard adult titration starts at 20 mg once daily in the morning. The prescriber may increase by 5 to 10 mg increments at weekly or biweekly intervals based on response and tolerability. The FDA-approved maximum dose for adult ADHD is 30 mg/day. Some clinicians titrate above 30 mg under careful monitoring, though doses above 40 mg/day have not demonstrated additional efficacy in randomized trials. [13]

Common side effects at therapeutic doses include decreased appetite (reported in 22 to 35% of adults in key trials), insomnia (11 to 27%), dry mouth (35%), and headache (14 to 26%). [1] Most side effects are dose-dependent and improve with dose reduction.

Adderall XR capsules can be swallowed whole or opened and sprinkled on a tablespoon of applesauce. The beads should not be crushed or chewed, as this destroys the extended-release mechanism and converts the dose to an immediate-release profile. [1]

Prior Authorization Requirements in Indiana

Many Indiana commercial insurers require prior authorization (PA) for Adderall XR, particularly the brand-name product. Generic mixed amphetamine salts ER (manufactured by Teva, Lannett, and others) are usually on lower tiers and may not require PA.

A typical Indiana prior-authorization packet for Adderall XR includes the following documentation. The prescriber must submit a DSM-5 diagnosis code (F90.0, F90.1, or F90.2 for ADHD; G47.419 for narcolepsy), evidence that the patient has tried and failed or is intolerant to a first-line generic stimulant, baseline symptom severity rating scale scores, and confirmation that INSPECT was checked. [14]

The American Academy of Child and Adolescent Psychiatry's 2020 Practice Parameter states: "Prior authorization requirements for stimulant medications create clinically meaningful treatment delays and should be minimized." [15] When PA is denied, most Indiana plans have a peer-to-peer review process; the prescriber calls the plan's medical director and presents the clinical rationale. Approval rates after peer-to-peer review exceed 70% in most reported analyses. [16]

Indiana Medicaid (Hoosier Health) does not cover Adderall XR for ADHD or narcolepsy as of the 2025 preferred drug list. Patients enrolled in Medicaid may request a medical necessity exception, but approval rates are low. A 90-day supply of generic mixed amphetamine salts ER purchased at cash price runs approximately $60 to $130 at Indiana GoodRx-participating pharmacies, making cash pay a viable option for Medicaid patients who cannot secure PA.

Transferring an Out-of-State Adderall XR Prescription to Indiana

You cannot transfer a Schedule II prescription. Federal law (21 CFR 1306.05) prohibits the transfer of any Schedule II controlled-substance prescription between pharmacies, regardless of state. If you are moving to Indiana with an active Adderall XR prescription from another state, you have two options.

First, ask your current prescriber to send a new electronic prescription to an Indiana pharmacy before you move. The prescriber must hold an active DEA registration that covers Indiana, or register in Indiana before signing. Most physicians can register with the Indiana Professional Licensing Agency within 2 to 4 weeks.

Second, establish care with an Indiana prescriber and present prior treatment records to expedite the evaluation. Bringing a copy of your current prescription, prior clinical notes documenting the ADHD diagnosis, and recent INSPECT records from your prior state helps the Indiana prescriber confirm continuity of treatment and reduces the chance of a gap in therapy. [6]

503A Compounding Pharmacies in Indiana for Mixed Amphetamine Salts

Licensed 503A compounding pharmacies in Indiana can prepare mixed amphetamine salts for patients who have documented intolerances to excipients in commercial Adderall XR capsules (such as specific dyes or fillers). A 503A pharmacy may compound only on receipt of a valid patient-specific prescription from a licensed prescriber. They cannot manufacture bulk quantities or sell compounded Schedule II products without a prescription.

The FDA distinguishes 503A pharmacies (patient-specific, prescription-required) from 503B outsourcing facilities (bulk manufacturing, hospital supply). As of 2025, mixed amphetamine salts are not on the FDA's 503B outsourcing facility drug shortage list, so bulk compounding by 503B facilities is not permitted for this compound. [4]

If you require a compounded formulation, ask your prescriber to specify the exact strength, dosage form, and any excipient exclusions on the prescription. The Indiana Board of Pharmacy (IAC 856) regulates 503A compounders and maintains a licensee lookup at in.gov/pla. Patients should verify a pharmacy's active state compounding license before submitting a Schedule II prescription.

What to Expect at Indiana Pharmacies

Adderall XR and generic mixed amphetamine salts ER have been subject to intermittent national shortages since the FDA first declared an amphetamine shortage in October 2022. [4] Indiana pharmacies follow the same supply constraints as the national market.

When picking up your first fill, bring a government-issued photo ID. The pharmacist is required to verify your identity and log the dispensing in the state's INSPECT system within 24 hours. Most Indiana chain pharmacies can transfer your profile between branches within the same chain, which can help if your usual location is out of stock. Independent pharmacies sometimes have better access to alternative manufacturers' stock.

Generic manufacturers currently supplying the Indiana market include Teva, Lannett, Alvogen, and Aurobindo. Bioequivalence between manufacturers is established by FDA standards (within 80 to 125% of the reference listed drug for AUC and Cmax), but some patients report subjective differences between manufacturers. [17] If you notice a change in effect after a manufacturer switch, document the NDC number on your prescription bottle and discuss with your prescriber.

Monitoring After You Start Adderall XR

After starting Adderall XR, your prescriber should schedule a follow-up within 2 to 4 weeks to assess symptom response, side effects, blood pressure, and heart rate. The Vanderbilt Assessment Scale or the Adult ADHD Rating Scale (ADHD-RS-IV) is often used to quantify improvement from baseline. [18]

Long-term safety monitoring includes blood pressure checks at every visit, weight at least every 6 months, and annual reassessment of whether the diagnosis remains appropriate. Growth monitoring applies to pediatric patients; Adderall XR may reduce growth velocity by approximately 1 to 2 cm per year in the first 1 to 3 years of treatment, with partial catch-up growth after that period. [19]

Patients should return to their prescriber before their 30-day supply runs out, as early refills cannot be dispensed by Indiana pharmacies for Schedule II substances. Plan appointments at least 5 to 7 business days before your last tablet to avoid a prescription gap.